Anew Medical, Inc. – NASDAQ:WENA

$1.73

+0.10

+6.79%

Market closed

Open in 2 days

Market Cap	15.43M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Anew Medical, Inc. (NASDAQ:WENA): Profit margin
2023	0	1.34M

Anew Medical, Inc. (NASDAQ:WENA): Debt to assets
2023	19455953	8.24M	42.36%

Anew Medical, Inc. (NASDAQ:WENA): Cash Flow
2022	-493.04K	-116.15M	116.97M
2023	-1.26M	101.91M	-100.81M

Anew Medical alternative data

Anew Medical, Inc. (NASDAQ:WENA): Employee count
Jul 2024	1
Dec 2024	1

Anew Medical, Inc. (NASDAQ:WENA): Insider trades (number of shares)
Period	Buy	Sel
Jun 2024	0	47000
Jul 2024	0	295136

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	2 Jul 2024	CHARDAN CAPITAL MARKETS LLC 10 percent owner 10 percent owner	Common Stock	180,000	$2.05	$368,460
Sale	1 Jul 2024	CHARDAN CAPITAL MARKETS LLC 10 percent owner 10 percent owner	Common Stock	115,136	$2.06	$237,641
Sale	28 Jun 2024	CHARDAN CAPITAL MARKETS LLC 10 percent owner 10 percent owner	Common Stock	47,000	$2.53	$119,098

Anew Medical
Latest News

Tuesday, 17 September 2024
06:30	ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.	prismmediawire.com
06:30	ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.	globenewswire.com
Wednesday, 4 September 2024
07:47	Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy	prismmediawire.com
07:46	Healthy Longevity is One of Key Development Goals of ANEW's Novel Gene Therapy	globenewswire.com
Monday, 26 August 2024
05:01	ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility	prismmediawire.com
05:00	ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility	globenewswire.com
Wednesday, 21 August 2024
05:04	ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)	prismmediawire.com
05:00	ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)	globenewswire.com
Monday, 19 August 2024
05:00	ANEW MEDICAL, INC. Appoints New CFO	prismmediawire.com
05:00	ANEW MEDICAL, INC. Appoints New CFO	globenewswire.com
Thursday, 15 August 2024
05:00	ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases	prismmediawire.com
05:00	ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases	globenewswire.com
Friday, 9 August 2024
05:00	ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides	prismmediawire.com
05:00	ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides	globenewswire.com
Thursday, 8 August 2024
08:37	4 Stocks Moving Sharply Before the Market Opens	247wallst.com
08:10	Why Is Anew Medical (WENA) Stock Up 37% Today?	investorplace.com
Tuesday, 9 July 2024
08:09	Why Is Anew Medical (WENA) Stock Up 51% Today?	investorplace.com
05:30	ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments	prismmediawire.com
05:30	ANEW MEDICAL to Advance Patented Klotho Gene Therapy for Neurodegenerative Disorder Treatments	globenewswire.com
Thursday, 27 June 2024
05:47	ANEW MEDICAL Forms Strategic Partnership with Japan's Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene	prismmediawire.com
05:00	ANEW MEDICAL Forms Strategic Partnership with Japan's Okinawa Research Center for Longevity Science (ORCLS) to Study Klotho Gene	globenewswire.com
Wednesday, 26 June 2024
08:09	Why Is Anew Medical (WENA) Stock Up 144% Today?	investorplace.com

Frequently Asked Questions (FAQ)

What's the price of Anew Medical stock today?

One share of Anew Medical stock can currently be purchased for approximately $1.73.
When is Anew Medical's next earnings date?

Unfortunately, Anew Medical's (WENA) next earnings date is currently unknown.
Does Anew Medical pay dividends?

No, Anew Medical does not pay dividends.
How much money does Anew Medical make?

Anew Medical has a market capitalization of 15.43M.
What is Anew Medical's stock symbol?

Anew Medical, Inc. is traded on the NASDAQ under the ticker symbol "WENA".
What is Anew Medical's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Anew Medical?

Shares of Anew Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Anew Medical have?

As Dec 2024, Anew Medical employs 1 workers.
What is Anew Medical's official website?

The official website for Anew Medical is anewmeds.com.
Where are Anew Medical's headquarters?

Anew Medical is headquartered at 13576 Walnut Street, Omaha, NE.
How can i contact Anew Medical?

Anew Medical's mailing address is 13576 Walnut Street, Omaha, NE and company can be reached via phone at 833 931 6330.

Anew Medical, Inc.

anewmeds.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

833 931 6330

13576 Walnut Street
Omaha, NE 68144

:
ISIN: US03465T1088
: